Literature DB >> 25819140

Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1).

Choon Jin Ooi1, Govind K Makharia2, Ida Hilmi3, Peter R Gibson4, Kwong Ming Fock5, Vineet Ahuja2, Khoon Lin Ling1, Wee Chian Lim6, Kelvin T Thia1, Shu-chen Wei7, Wai Keung Leung8, Poh Koon Koh9, Richard B Gearry10, Khean Lee Goh3, Qin Ouyang11, Jose Sollano12, Sathaporn Manatsathit13, H Janaka de Silva14, Rungsun Rerknimitr15, Pises Pisespongsa16, Muhamad Radzi Abu Hassan17, Joseph Sung18, Toshifumi Hibi19, Christopher C M Boey20, Neil Moran21, Rupert W L Leong21.   

Abstract

Inflammatory bowel disease (IBD) was previously thought to be rare in Asia, but emerging data indicate rising incidence and prevalence of IBD in the region. The Asia Pacific Working Group on Inflammatory Bowel Disease was established in Cebu, Philippines, at the Asia Pacific Digestive Week conference in 2006 under the auspices of the Asian Pacific Association of Gastroenterology with the goal of developing best management practices, coordinating research, and raising awareness of IBD in the region. The consensus group previously published recommendations for the diagnosis and management of ulcerative colitis with specific relevance to the Asia-Pacific region. The present consensus statements were developed following a similar process to address the epidemiology, diagnosis, and management of Crohn's disease. The goals of these statements are to pool the pertinent literature specifically highlighting relevant data and conditions in the Asia-Pacific region relating to the economy, health systems, background infectious diseases, differential diagnoses, and treatment availability. It does not intend to be all comprehensive and future revisions are likely to be required in this ever-changing field.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Crohn; IBD; consensus; definition; diagnosis; epidemiology; gastroenterology; guidelines; incidence; investigation

Mesh:

Year:  2016        PMID: 25819140     DOI: 10.1111/jgh.12956

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  31 in total

1.  Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.

Authors:  Zhenyu Yang; Chibin Bu; Wei Yuan; Zhaohua Shen; Yongsheng Quan; Shuai Wu; Changxin Zhu; Xiaoyan Wang
Journal:  Dig Dis Sci       Date:  2019-07-31       Impact factor: 3.199

2.  LRRK2 but not ATG16L1 is associated with Paneth cell defect in Japanese Crohn's disease patients.

Authors:  Ta-Chiang Liu; Takeo Naito; Zhenqiu Liu; Kelli L VanDussen; Talin Haritunians; Dalin Li; Katsuya Endo; Yosuke Kawai; Masao Nagasaki; Yoshitaka Kinouchi; Dermot Pb McGovern; Tooru Shimosegawa; Yoichi Kakuta; Thaddeus S Stappenbeck
Journal:  JCI Insight       Date:  2017-03-23

Review 3.  Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.

Authors:  Julajak Limsrivilai; Andrew B Shreiner; Ananya Pongpaibul; Charlie Laohapand; Rewat Boonanuwat; Nonthalee Pausawasdi; Supot Pongprasobchai; Sathaporn Manatsathit; Peter D R Higgins
Journal:  Am J Gastroenterol       Date:  2017-01-03       Impact factor: 10.864

4.  Imaging of the small intestine in Crohn's disease: Joint position statement of the Indian Society of Gastroenterology and Indian Radiological and Imaging Association.

Authors:  Saurabh Kedia; Raju Sharma; Govind K Makharia; Vineet Ahuja; Devendra Desai; Devasenathipathy Kandasamy; Anu Eapen; Karthik Ganesan; Uday C Ghoshal; Naveen Kalra; D Karthikeyan; Kumble Seetharama Madhusudhan; Mathew Philip; Amarender Singh Puri; Sunil Puri; Saroj K Sinha; Rupa Banerjee; Shobna Bhatia; Naresh Bhat; Sunil Dadhich; G K Dhali; B D Goswami; S K Issar; V Jayanthi; S P Misra; Sandeep Nijhawan; Pankaj Puri; Avik Sarkar; S P Singh; Anshu Srivastava; Philip Abraham; B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2018-01-06

Review 5.  Restriction of FODMAP in the management of bloating in irritable bowel syndrome.

Authors:  Wei Mon Wong
Journal:  Singapore Med J       Date:  2016-09       Impact factor: 1.858

Review 6.  The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West?

Authors:  Rashid N S Lui; Siew C Ng
Journal:  Inflamm Intest Dis       Date:  2016-07-15

7.  Differentiation of intestinal tuberculosis and Crohn's disease through an explainable machine learning method.

Authors:  Futian Weng; Yu Meng; Fanggen Lu; Yuying Wang; Weiwei Wang; Long Xu; Dongsheng Cheng; Jianping Zhu
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

8.  Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.

Authors:  Berkeley N Limketkai; Zipporah Iheozor-Ejiofor; Teuta Gjuladin-Hellon; Alyssa Parian; Laura E Matarese; Kelly Bracewell; John K MacDonald; Morris Gordon; Gerard E Mullin
Journal:  Cochrane Database Syst Rev       Date:  2019-02-08

9.  Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease.

Authors:  Kai-Chun Wu; Zhi Hua Ran; Xiang Gao; Minhu Chen; Jie Zhong; Jian-Qiu Sheng; Michael A Kamm; Simon Travis; Kori Wallace; Nael M Mostafa; Marisa Shapiro; Yao Li; Roopal B Thakkar; Anne M Robinson
Journal:  Intest Res       Date:  2016-04-27

10.  RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis.

Authors:  Karel P Alcedo; Saisathya Thanigachalam; Saleh A Naser
Journal:  Gut Pathog       Date:  2016-06-14       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.